New products
First patient treated in Airiver Medical’s RESTORE-2 trial for CRS
Airiver Medical has enrolled the first patient in its RESTORE-2 pivotal trial of the ESSpand Sinus drug-coated balloon (DCB) for chronic rhinosinusitis treatment. The trial will evaluate the device's safety and efficacy in expanding and treating inflamed sinus passages. ESSpand represents a minimally invasive alternative to traditional sinus surgery.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network